Redox Revolution

FDA To Review 12 Peptides: What It Means Moving Forward

33 min · Eilen
jakson FDA To Review 12 Peptides: What It Means Moving Forward kansikuva

Kuvaus

The FDA recently announced it will review the safety and efficacy of a number of powerful peptides. In 2023, based on safety concerns and reports that providers were treating patients irresponsibly, the FDA assigned a number of peptides for Category 2, effectively banning US pharmacies from compounding them. Today, Dr. Seeds addresses the why, the how, and the what’s next. Learn more about SSRP Institute [https://ssrpinstitute.org/]  Follow for more! Instagram: @williamseedsmd [https://www.instagram.com/williamaseedsmd/] | @redoxmedicalgroup [https://www.instagram.com/redoxmedicalgroup/] Youtube: Subscribe Here [https://www.youtube.com/channel/UCqECEb71Ybc-kPtg7ITtuAw?sub_confirmation=1]

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity Redox Revolution-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

66 jaksot